period
strong result improv outlook
encourag howev need deliv top-line
growth much tougher comparison well deliv
ramp synergi goal stock work
net see balanc risk/reward remain ew
move right direct weak start year stock
ytd ralli follow much better expect
print key season quarter includ strong organ top-line
growth bp market expect well much tighter sg
cost control led sizabl profit beat vs consensu although
modest beat vs mse overal result mark progress
number front includ organ top-line trend surpris posit
y-o-i vs market expect rang well
averag declin prior quarter fuel strong result luxuri
vs mse stabil consum beauti vs mse
strength emerg market off-set weak us momentum appear
build guidanc call modestli posit organ
growth vs flat prior major brand relaunch covergirl/clairol expect
drive recoveri us consum beauti trend shelf space stabil
expect flat y-o-i year declin growth accret deal
younique/ghd move organ base ii regard profit deliv
y-o-i ebit growth driven much tighter expens manag sg
bp y-o-i sale help off-set bp y-o-i declin
gross margin due neg mix emerg market well
lap difficult year ago comparison due manufactur varianc
also reiter expect deliv announc synergi healthi
margin improv balanc year notabl
improv expect come
outlook much demand strong result
improv outlook encourag fundament bar
significantli higher first need deliv top-line growth much
tougher comparison guidanc assum y-o-i growth impli
household person unit state america
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
strong improv averag growth vs
look somewhat demand challeng us consum beauti categori
backdrop profit perspect model dd profit upsid vs
consensu head deliv thesi
underpin easi comparison favor impact margin
expans driven synergi realiz achiev view
creat higher bar net remain equal-weight see
balanc risk/reward current valuat cautiou long-term top-line
outlook off-set potenti rebound near-term top-line trend greater
innov still easi comparison well sizabl synergi driven margin
number ep well consensu
estim mse revenu upsid vs consensu much tighter
sg cost control bp consensu sale off-set
lower expect gross margin bp consensu led
sizabl profit beat mse line lower tax rate ad
cent vs mse organ sale growth stronger expect
market expect like rang led strong result
luxuri profession respect partial off-set continu
weak consum beauti larg sequenti improv
declin net cash oper
vs last year larg due one-tim benefit relat ramp
account payabl accru expens follow close
beauti acquisit last state expect us tax reform neutral
earn cash flow
updat ep estim follow ep rais ep
ep upsid off-set slightli higher assum
brand reinvest well higher tax rate/minor interest
ep estim move
larg higher tax rate/minor interest well greater assum brand
reinvest pt base ebitda
estim discount back cost equiti
deriv base case scenario
bull case pf ebitda discount back
bull case pf ebitda discount back
revenu upsid drive multipl expans top-line margin upsid
better-than-expect volum rebound market share/innov
increment cost-cut valuat re-rat bull case
pro forma ebitda discount back cost equiti
base pf ebitda discount
base pf ebitda discount back
mute top-line growth forecast lsd organ sale growth
given coti weak brand equiti sub-optim skew fragranc mass
product howev signific synergi realiz recent drive
profit growth appli multipl pro forma ebitda
discount back toward lower end peer given weaker top-line
growth high near-term execut risk
bear pf ebitda discount
bear pf ebitda discount back
fundament weaken market share loss hurt volum bp
execut hiccup weak brand equiti competit environ hurt
price bp synergi downsid weigh margin multipl
compress pro forma bear case ebitda discount back
cost equiti
exhibit bear bull driver top-line growth cut
mute top-line growth outlook
pg transact expect soft
heritag busi acquir pg
brand continu albeit improv
sequenti greater manag
attention/focu easier comparison long-
term expect gradual improv
lsd organ sale growth
msd growth beauti peer el
profit growth remain cautiou
long-term growth outlook see
signific margin opportun unlock
synergi pg transact
still unreal synergi
remain program equat
nearli ebit key
driver behind om forecast
valuat look fair pro
forma ebitda
trade valuat discount hpc
compani attract beauti peer
believ properli reflect
sub-optimal beauti posit near-term
risk achiev price
risk includ licens
save realiz deal integr risk
act financi advisor procter gambl compani pg connect
on-going sharehold relat assign pg agre pay fee servic pleas refer
note end report
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report dara
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
import us regulatori disclosur subject compani
januari benefici own class common equiti secur follow compani cover morgan
within last month manag co-manag public offer offer secur clorox co co elf
within last month receiv compens invest bank servic clorox co co elf beauti
next month expect receiv intend seek compens invest bank servic buffalo pet product inc
within last month receiv compens product servic invest bank servic church
within last month provid provid invest bank servic invest bank client relationship
follow compani buffalo pet product inc church dwight co inc clorox co co inc elf
within last month either provid provid non-invest bank securities-rel servic and/or past
enter agreement provid servic client relationship follow compani church dwight co inc clorox co colgate-palmol
employe director consult director este lauder compani inc person research analyst member
 co llc make market secur buffalo pet product inc church dwight co inc clorox co co
equiti research analyst strategist princip respons prepar research receiv compens base upon
variou factor includ qualiti research investor client feedback stock pick competit factor firm revenu overal invest bank
revenu equiti research analyst strategist compens link invest bank capit market transact perform morgan
stanley profit revenu particular trade desk
affili busi relat companies/instru cover research includ market make provid
liquid fund manag commerci bank extens credit invest servic invest bank sell buy
custom securities/instru compani cover research princip basi may posit debt
compani instrument discuss report trade may trade princip debt secur relat deriv
subject debt research report
certain disclosur list also complianc applic regul non-u jurisdict
